PE ratio relative to earnings growth — is the valuation justified?
—
PEG Ratio
Negative earnings — PE and PEG ratios are not meaningful
—
Current Price
$64.88
TTM EPS
$-6.70
P/E Ratio
—
Growth Rate
—
N/A
Sector
Healthcare
Biotechnology
Calculated
8/18/2026
10:19:53 AM
PEG Ratio Unavailable
Insufficient price/EPS data
Peer Comparison
Sample Size
3 peers
Industry Median PEG
0.34
25th Percentile
0.25
75th Percentile
11.69
Symbol
Company
PEG
P/E
Growth
vs NKTR
INCY
Incyte Corporation
0.25
15.7
62.7%
—
EXEL
Exelixis, Inc.
0.34
17.8
51.6%
—
NBIX
Neurocrine Biosciences, Inc.
11.69
22.7
1.9%
—
How to Interpret PEG Ratio
PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.
PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."
PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.
Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.
